Intensive interventions to reduce blood glucose and blood pressure levels in type 2 diabetes reduce the risk of developing cardiovascular autonomic neuropathy (CAN), a frequent but underdiagnosed complication of diabetes ...
Dec 16, 2020
0
7
(HealthDay)—For patients with COVID-19, hyperglycemia and hypoglycemia are associated with poor outcomes, according to a study published online Dec. 15 in Diabetes Care.
Dec 16, 2020
0
4
Vanderbilt University Medical Center researchers have discovered individuals with type 1 and type 2 diabetes infected with COVID-19 are three times more likely to have a severe illness or require hospitalization compared ...
Dec 4, 2020
0
7
Diabetes is currently treated using incretin hormones to reduce the risk of cardiovascular disease and other medical issues that the illness can trigger. Now researchers from Lund University in Sweden have noted new links ...
Nov 19, 2020
0
2
New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available. A University of Gothenburg study shows that using the CGM tool, with its continuous ...
Nov 16, 2020
0
4
(HealthDay)—There are disparities in access to the internet among those with chronic health conditions such as hypertension and diabetes, according to a research letter published online Nov. 2 in Diabetes Care.
Nov 10, 2020
0
2
(HealthDay)—As the COVID-19 pandemic spread throughout the United States, many people changed the way they live: As shopping, education and work shifted online, so did routine health care appointments.
Nov 4, 2020
0
4
Patients with Type 2 diabetes often take metformin as first-line therapy to help stabilize their blood glucose. Eventually, some patients no longer respond to metformin and require additional treatment. A few years ago, pivotal ...
Nov 2, 2020
0
10
Children with multiple islet autoantibodies—biological markers of autoimmunity—are more likely to progress to symptomatic type 1 diabetes (T1D) than those who remain positive for a single autoantibody.
Oct 29, 2020
0
17
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy. Patients given sitagliptin in addition ...
Sep 29, 2020
0
285
